ImmuneBridge
United States
activeseries-a
series-a
Stage
2
Investors
About
ImmuneBridge develops allogeneic cellular immunotherapies using a proprietary stem cell expansion technology to create scalable, high-quality immune cell therapies for cancer and other diseases.
Explore ImmuneBridge's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.